Study Points To Viral Infection As A Trigger For Parkinson’s-Like Symptoms

A Mouse Virus Recreates Parkinson’s-Like Brain Damage Without a Single Neurotoxin

For decades, scientists studying Parkinson’s disease have relied on poisoning brain cells with toxic chemicals to mimic the disease. That method works well enough in the lab, but it has an obvious flaw, since people don’t typically develop Parkinson’s from exposure to powerful neurotoxins. Researchers at Texas A&M University say they’ve found a different path, using a naturally occurring mouse virus to reproduce the same pattern of brain damage seen in Parkinson’s patients, without a drop of synthetic poison involved.

Parkinson’s disease affects more than ten million people worldwide, the second most common neurodegenerative disorder. It slowly destroys brain cells that produce dopamine, a chemical messenger that controls movement. Once enough cells die, tremors, stiffness, and a shuffling walk set in. Scientists still don’t fully understand what triggers the disease, though brain inflammation tied to viral infection has drawn growing suspicion.

Published in Brain, Behavior, & Immunity – Health, the study turned to Theiler’s murine encephalomyelitis virus, or TMEV, a natural mouse pathogen long used to study multiple sclerosis and epilepsy. Prior research had shown TMEV could infect and destroy the same dopamine-producing cells lost in Parkinson’s disease. What hadn’t been tested was whether that destruction actually caused the tremors and stiffness that define the condition.

Injecting the Virus Produces Parkinson’s-Like Symptoms in Mice

Researchers injected TMEV directly into the brain region where dopamine-producing cells live, in adult male mice between 8 and 12 weeks old. It’s a step closer to real biology than the neurotoxin models, since it uses an actual pathogen instead of a synthetic chemical, though it still means injecting the virus straight into the brain rather than letting it spread the way a real infection would. A control group underwent the same surgery without the virus. Researchers then tracked 13 infected mice and 14 controls over 20 weeks to see whether Parkinson’s-like symptoms would develop.

One test placed mice atop a vertical wooden pole and timed how long they took to turn around and climb down, a standard way to measure coordination problems tied to the targeted brain region. Infected mice were consistently slower than controls, most clearly in the first month and again later in the study, though the difference wasn’t always as sharp week to week.

A Parkinson’s Drug Reveals the Scope of Brain Damage

To gauge the extent of one-sided brain damage, the team also turned to apomorphine, a drug used to treat Parkinson’s in humans. When dopamine-producing neurons are damaged on one side, dopamine receptors in that circuit become unusually sensitive to compensate for the loss. Apomorphine activates those receptors and sends mice spinning in circles toward the side opposite the injury, a strange but reliable side effect. More rotation generally signals a bigger loss of dopamine neurons on the injected side.

Mice injected with TMEV spun far more than controls at every time point, one week through 20 weeks after injection. There was no difference between groups before surgery, pointing to a single infection producing damage that lasted the full length of the study.

A third test tracked the mice walking on a treadmill, and it turned up one small but telling detail: infected mice pushed off with their left front paw differently than the control mice, a change that lines up with damage to the right side of the brain, which controls the left side of the body.

Virus Vanishes Quickly, Yet the Damage Outlasts It

Brain tissue analysis turned up one of the study’s most telling findings. At one week, researchers confirmed under a microscope that TMEV had infected dopamine-producing cells at the injection site. By four weeks, those cells had thinned out noticeably on the injected side, and by that point the virus itself was gone, undetectable in the brain tissue. That timing matters: the motor symptoms that lasted all the way to week 20 don’t look like the work of an active, ongoing infection. Instead, researchers suspect the initial viral attack set off inflammation and immune activity that kept damaging the dopamine system long after the virus itself had cleared out.

Study authors describe this as a pilot project with real limitations. The mice used clear the virus quickly, which helps isolate early damage but may not capture a more prolonged viral illness. Only male mice were tested, and results varied somewhat week to week. TMEV is also specific to mice and has no known effect on humans, so it cannot directly model human viral exposure.

Future work, the study authors say, should examine immune responses in the brain, test the model in other mouse strains, and compare it with the chemical-based models that dominate current Parkinson’s research. Still, the core finding stands: a naturally occurring virus can destroy the very brain cells that die off in Parkinson’s disease and produce the kind of motor symptoms seen in the condition, without a single synthetic neurotoxin.

If some viral infections turn out to contribute to Parkinson’s risk in people, models like this could help researchers figure out the path from infection to inflammation to lasting brain damage.

---

Disclaimer: This article is based on a peer-reviewed animal study and is intended for general informational purposes only. It does not constitute medical advice. Findings from mouse models do not necessarily translate to humans, and TMEV has no known effect on human health.

---